Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevonescein in Head & Neck Surgery
NCT04420689Phase 2Completed
- Sponsor
- Alume Biosciences
- Start
- Jun 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of bevonescein in head and neck neoplasms (HNN), sponsored by Alume Biosciences. Started Jun 2020; status: completed.
02
Drugs
bevonescein
03
Conditions
head and neck neoplasms (HNN)
Beyond the preview
Go deeper on NCT04420689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420689.